FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Séverine Morisset

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Co-author Network

Publications

TOP 3
Mouhammad Motawaj; Aude Burban; Elisabeth Davenas; Florence Gbahou; Raphaël Faucard; Séverine Morisset; Jean-Michel Arrang
[The histaminergic system: a target for innovative treatments of cognitive deficits].
F Gbahou; E Davenas; Séverine Morisset; Jean-Michel Arrang
Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
Jean-Michel Arrang; Séverine Morisset; Florence Gbahou
Constitutive activity of the histamine H3 receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Séverine Morisset (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Mouhammad Motawaj; Aude Burban; Elisabeth Davenas; Florence Gbahou; Raphaël Faucard; Séverine Morisset; Jean-Michel Arrang
[The histaminergic system: a target for innovative treatments of cognitive deficits].
Thérapie 2010;65(5):415-22.
2010: F Gbahou; E Davenas; Séverine Morisset; Jean-Michel Arrang
Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
The Journal of pharmacology and experimental therapeutics 2010;334(3):945-54.
2007: Jean-Michel Arrang; Séverine Morisset; Florence Gbahou
Constitutive activity of the histamine H3 receptor.
Trends in pharmacological sciences 2007;28(7):350-7.
2007: Marie Humbert-Claude; Séverine Morisset; Florence Gbahou; Jean-Michel Arrang
Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
Biochemical pharmacology 2007;73(8):1172-81.
2003: Florence Gbahou; Agnès Rouleau; Séverine Morisset; Régis Parmentier; Sylvain Crochet; Jian-Sheng Lin; Xavier Ligneau; Joël Tardivel-Lacombe; Holger Stark; Walter Schunack; C Robin Ganellin; Jean-Charles Schwartz; Jean-Michel Arrang
Protean agonism at histamine H3 receptors in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):11086-91.
2003: Jean-Charles Schwartz; Séverine Morisset; Agnès Rouleau; Xavier Ligneau; Florence Gbahou; Joël Tardivel-Lacombe; Holger Stark; Walter Schunack; C Robin Ganellin; Jean-Michel Arrang
Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor.
Journal of neural transmission. Supplementum 2003;(64):1-16.
2002: Séverine Morisset; C Pilon; Joël Tardivel-Lacombe; D Weinstein; W Rostene; C Betancur; Pierre Sokoloff; Jean-Charles Schwartz; Jean-Michel Arrang
Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.
The Journal of pharmacology and experimental therapeutics 2002;300(2):621-8.
2002: Agnès Rouleau; Xavier Ligneau; Joël Tardivel-Lacombe; Séverine Morisset; Florence Gbahou; Jean-Charles Schwartz; Jean-Michel Arrang
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
British journal of pharmacology 2002;135(2):383-92.
2001: Jean-Charles Schwartz; Séverine Morisset; Agnès Rouleau; Joël Tardivel-Lacombe; Florence Gbahou; Xavier Ligneau; Anne Héron; Astrid Sasse; Holger Stark; Walter Schunack; R C Ganellin; Jean-Michel Arrang
Application of genomics to drug design: the example of the histamine H3 receptor.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(6):441-8.
2001: Joël Tardivel-Lacombe; Séverine Morisset; Florence Gbahou; Jean-Charles Schwartz; Jean-Michel Arrang
Chromosomal mapping and organization of the human histamine H3 receptor gene.
Neuroreport 2001;12(2):321-4.
2001: Séverine Morisset; Astrid Sasse; Florence Gbahou; Anne Héron; Xavier Ligneau; Joël Tardivel-Lacombe; Jean-Charles Schwartz; Jean-Michel Arrang
The rat H3 receptor: gene organization and multiple isoforms.
Biochemical and biophysical research communications 2001;280(1):75-80.
2000: Séverine Morisset; Agnès Rouleau; Xavier Ligneau; Florence Gbahou; Joël Tardivel-Lacombe; Holger Stark; Walter Schunack; C Robin Ganellin; Jean-Charles Schwartz; Jean-Michel Arrang
High constitutive activity of native H3 receptors regulates histamine neurons in brain.
Nature 2000;408(6814):860-4.
2000: Xavier Ligneau; Séverine Morisset; Joël Tardivel-Lacombe; Florence Gbahou; C Robin Ganellin; Holger Stark; Walter Schunack; Jean-Charles Schwartz; Jean-Michel Arrang
Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.
British journal of pharmacology 2000;131(7):1247-50.
2000: Joël Tardivel-Lacombe; Agnès Rouleau; Anne Héron; Séverine Morisset; Catherine Pillot; Véronique Cochois; Jean-Charles Schwartz; Jean-Michel Arrang
Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms.
Neuroreport 2000;11(4):755-9.
2000: C Ito; Séverine Morisset; Marie-Odile Krebs; Jean-Pierre Olié; Henri Lôo; Marie-France Poirier; Lars Lannfelt; Jean-Charles Schwartz; Jean-Michel Arrang
Histamine H2 receptor gene variants: lack of association with schizophrenia.
Molecular psychiatry 2000;5(2):159-64.
2000: Séverine Morisset; Elisabeth Traiffort; Jean-Michel Arrang; Jean-Charles Schwartz
Changes in histamine H3 receptor responsiveness in mouse brain.
Journal of neurochemistry 2000;74(1):339-46.
1999: Séverine Morisset; U G Sahm; Elisabeth Traiffort; Joël Tardivel-Lacombe; Jean-Michel Arrang; Jean-Charles Schwartz
Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
The Journal of pharmacology and experimental therapeutics 1999;288(2):590-6.